4.6 Review

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy

Journal

DIAGNOSTICS
Volume 11, Issue 9, Pages -

Publisher

MDPI
DOI: 10.3390/diagnostics11091720

Keywords

microRNAs; biomarkers; inherited cardiomyopathies; dilated cardiomyopathy; arrhythmogenic cardiomyopathy; hypertrophic cardiomyopathy

Ask authors/readers for more resources

MiRNAs are small non-coding RNAs involved in regulating biochemical pathways in the human body; their levels can be altered due to pathophysiological mechanisms, making them potential biomarkers for cardiac diseases and other pathological conditions. This review summarizes findings of miRNA biomarkers in the three most common structural cardiomyopathies.
MicroRNAs (miRNAs) are a class of non-coding RNAs of about 20 nucleotides in length, involved in the regulation of many biochemical pathways in the human body. The level of miRNAs in tissues and circulation can be deregulated because of altered pathophysiological mechanisms; thus, they can be employed as biomarkers for different pathological conditions, such as cardiac diseases. This review summarizes published findings of these molecular biomarkers in the three most common structural cardiomyopathies: human dilated, arrhythmogenic and hypertrophic cardiomyopathy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available